Xuguang Hu
0009-0009-7264-9873
1 paper found
Refreshing results…
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Missing publications? Search for publications with a matching author name.